NCT03251690 Switching TDF/FTC/EFV to TDF/FTC/RPV VS Continuing TDF/FTC/EFV in HIV Patients With Complete Virological Suppression Status COMPLETED Phase NA
NCT03234400 A Phase 1, Randomized Pharmacokinetics and Safety Study of Extended Duration Dapivirine Vaginal Rings Status COMPLETED Phase PHASE1
NCT03227731 Immediate or Deferred Pre-exposure Prophylaxis for HIV Prevention: Safe Options for Pregnant and Lactating Women Status COMPLETED Phase PHASE2/PHASE3
NCT03226873 Peer Outreach and Navigation Intervention to Increase PrEP Uptake Among Women at High Risk for HIV Status COMPLETED Phase NA
NCT03199690 A Clinical Study Investigating Rifampicin and Dolutegravir in Combination in Healthy Volunteers Status UNKNOWN Phase PHASE1
NCT03198884 A Retrospective Study to Evaluate the Safety and Efficacy of a Nucleoside-Sparing Regimen of Darunavir, Ritonavir, and Dolutegravir Status COMPLETED Phase N/A
NCT03183154 Mathematical Modeling of the HIV Transmission Risk After Initiation of Antiretroviral Therapy in naïve HIV-infected Status UNKNOWN Phase N/A
NCT03174977 Pharmacokinetics Distribution of Raltegravir by PET/MR Status RECRUITING Phase EARLY_PHASE1
NCT03164135 Safety of Transplantation of CRISPR CCR5 Modified CD34+ Cells in HIV-infected Subjects With Hematological Malignances Status UNKNOWN Phase NA
NCT03160105 Evaluation of a Simplified Strategy for the Long-term Management of HIV Infection (Simpl'HIV) Status COMPLETED Phase PHASE4
NCT03129113 Adding MAraViroc &/or METformin for Hepatic Steatosis in People Living With HIV Status COMPLETED Phase PHASE2/PHASE3
NCT03118661 Maraviroc on HIV-1 Infected Subjects Who Require Allogeneic Hematopoietic Cell Transplant Status WITHDRAWN Phase PHASE1
NCT03110380 Switching to a Fixed Dose Combination of Bictegravir/Emtricitabine/Tenofovir Alafenamide (B/F/TAF) in Human Immunodeficiency Virus Type 1 (HIV-1) Infected Adults Who Are Virologically Suppressed Status COMPLETED Phase PHASE3
NCT03087890 Impact of Cotrimoxazole Use in Immunocompetent HIV Patients on Carriage of Antimicrobial Resistant Bacteria Status COMPLETED Phase PHASE4
NCT03075397 VIH-1 Colo-rectal Transmission by Infected Semen Cells and Effects of Seminal Plasma ex Vivo (CellspermVIH) Status COMPLETED Phase NA